TerrAscend (TSNDF) Tax Provisions (2021 - 2026)
TerrAscend's (TSNDF) quarterly Tax Provisions came in at $10.2 million in Q1 2026, down 2.45% year-on-year from $10.5 million in Q1 2025, and up 712.67% on a QoQ basis from -$1.7 million in Q4 2025.
TerrAscend (TSNDF) Tax Provisions (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Tax Provisions data on file, last reported at $10.2 million in Q1 2026.
- On a quarterly basis, Tax Provisions fell 2.45% year-over-year to $10.2 million in Q1 2026; TTM through Mar 2026 was $29.2 million, a 4084.86% increase from a year earlier, with the FY2025 full-year figure at $29.5 million, up 921.47% from the prior year.
- Tax Provisions for Q1 2026 stood at $10.2 million, up from -$1.7 million in the prior quarter.
- Over the last five years, Tax Provisions for TSNDF reached as high as $18.5 million in Q4 2022 and fell as low as -$34.0 million in Q3 2022.
- Historically, Tax Provisions has averaged $3.8 million across 5 years, with a median of $9.6 million in 2025.
- Across the five-year window, Tax Provisions surged 238.34% in 2023 and plunged 3515.13% in 2024, its largest moves.
- Year by year, Tax Provisions stood at $18.5 million in 2022, then slumped by 94.69% to $985000.0 in 2023, then plunged by 3515.13% to -$33.6 million in 2024, then jumped by 95.03% to -$1.7 million in 2025, then surged by 712.67% to $10.2 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $10.2 million in Q1 2026, -$1.7 million in Q4 2025, and $11.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 10.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.25 Mn |
| Dec 31, 2025 | -1.67 Mn |
| Sep 30, 2025 | 11.03 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | -33.64 Mn |
| Sep 30, 2024 | 13.27 Mn |
| Jun 30, 2024 | 9.13 Mn |
| Mar 31, 2024 | 9.67 Mn |
| Dec 31, 2023 | 985,000.00 |
| Sep 30, 2023 | 13.54 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 12.66 Mn |
| Dec 31, 2022 | 18.54 Mn |
| Sep 30, 2022 | -34.03 Mn |
| Jun 30, 2022 | 4.69 Mn |
| Mar 31, 2022 | 3.74 Mn |
| Dec 31, 2021 | 8.75 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 6.94 Mn |